IMMX Dividend: Immix Biopharma Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

IMMX Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	12	11	7	4	1	0
Research & Development	11	11	8	4	0	0
Operating Expenses	24	22	16	8	1	0
Other Non Operating Income (Expenses)	--	--	0	--	0	0
Pretax Income	-23	-21	-15	-8	-24	-1
Income Tax Expense	0	0	0	0	0	0
Net Income	-23	-21	-15	-8	-24	-1
Net Income Growth	10%	40%	88%	-67%	2,300%	--
Shares Outstanding (Diluted)	31.92	28.28	17.34	13.89	7.2	7.2
Shares Change (YoY)	9%	63%	25%	93%	0%	0%
EPS (Diluted)	-0.73	-0.76	-0.88	-0.59	-3.39	-0.16
EPS Growth	-1%	-14%	51%	-83%	2,019%	14%
Free Cash Flow	-15	-15	-11	-7	-1	0
Free Cash Flow Per Share	-0.46	-0.53	-0.63	-0.5	-0.13	0
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-24	-22	-16	-8	-1	0
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-24	-22	-16	-8	-1	0
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	0%